Technology
Platform
GliaX™
GliaPharm has established a proprietary drug discovery platform called GliaX™ to identify and characterize molecular targets and novel drug candidates that impact glial cell pathways.
GliaX™ is central to our own drug discovery process, but we also use it to help academic and industry partners with their research.
Specialized
Glial Assays
Cellular
Systems
Translational
In vivo Models
Brain metabolism
Morphology & activity
Cellular inflammation
Signaling cascades
Primary Brain cells
Human induced pluripotent stem cells (iPSCs)
Brain organoids with microelectrode array (MEA)
Neuron-Glia co-cultures
Intracerebral biosensors
EEG, FDG-PET, MRI
In vivo disease models
Harnessing the Power
of Glia
assays
Brain metabolism
Cellular Viability
Cellular inflammation
Signalling cascades
assays
Brain cell cultures
Human iPSC model cultures
In vivo brain metabolite analysis
Chemistry
Al-driven target modelling
In vitro target identification
Small molecule design
characterisation
technologies
Brain organoids
Digital Holography Microscopy
Behavioural
Tests
In-house behavioural capability in multiple rodent models
Translational
biomarkers
FDG PET/ MRI
EEG
Cerebrospinal Fluid (CSF)
